Finally, the action of androgens binding to the AR, prostate-specific antigen (PSA) levels, as well as changes in the 5α-reductase enzymes with aging/BPH and prostate cancer have been reviewed elsewhere [2,10,11,12,16,18,19,20,21]. Here, KLK3 is linked to benign prostatic hyperplasia.